from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2452c/-

LFCtreatmentdescriptionclass of inhibitor

-0.095

Amikacinug/mL Amikacintranslation

0.400

Cap5-10ug/mL Capreomycintranslation

1.733

Rox10-50 ug/mL Roxithromycintranslation

0.524

SM2-5 ug/mL Streptomycintranslation

-0.039

Tet5-10 ug/mL Tetracyclinetranslation

0.259

Rif0.2-5ug/mL Rifampicintranscription

-0.292

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.865

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.415

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.638

CPZ10-50 ug/mL Chlorpromazinerespiration

1.626

Clofazimine10-13 ug/mL Clofaziminerespiration

0.176

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.114

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.575

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.037

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.289

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.465

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.232

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.080

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.427

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.137

KCN5-20 ug/mL Potassium cyaniderespiration

0.619

NaN30.2-2 mM Sodium aziderespiration

1.626

Nigericin50 uM Nigericinrespiration

-0.301

TRC10-150 ug/mL Triclosanrespiration

-1.090

TRZ10-25 ug/mL Thioridazinerespiration

0.366

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.445

menadione6-10 ug/mL Menadionerespiration

0.452

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.060

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.008

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.139

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.618

NRP_1Non-replicating persistence stage 1dosRassociated

0.205

Amp0.2mg/mL AmpicillincellWall

-0.451

Cephalexin20-100 ug/mL CephalexincellWall

0.474

Cerulenin0.32-5 ug/mL CerulenincellWall

1.339

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.026

EMB10-20 ug/mL EthambutolcellWall

0.177

Eta12-40 ug/mL EthionamidecellWall

0.329

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.100

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.257

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.570

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.020

BZA0.12 mg/mL BenzamidearomaticAmides

-0.032

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.299

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.649

H2O24 mM hydrogen peroxideDNAdamaging

-0.391

Levo10 ug/mL LevofloxacinDNAdamaging

0.362

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.344

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.434

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.421

UVUV-irradiationDNAdamaging

0.469

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.115

Antimycin12.5-50 ug/mL Antimycin A?

-0.630

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.471

PA_110-50 ug/mL Antitubercular compound PA-1?

0.135

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.182

PA8240.2-2 ug/mL PA-824?

0.662

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.284

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.549

Verapamil50 uM Verapamil?

-0.434

mercaptoethanol2 mM 2-Mercaptoethanol?

0.271

methoxatin10-20 ug/mL Methoxatin?